Parrish Capital
ABBV icon

Parrish Capital’s AbbVie ABBV Stock Holding History

Parrish Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.65M Sell
6,300
-390
-6% -$100K 1.61% 18
2026
Q2 		$1.68M Sell
6,690
-1,172
-15% -$252K 1.62% 17
2026
Q1 		$1.71M Sell
7,862
-422
-5% -$93.6K 1.52% 21
2025
Q4 		$1.89M Buy
+8,284
New +$1.89M 1.71% 14

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Parrish Capital's ABBV Position: Q3 2026 in Review

Parrish Capital reduced its AbbVie (ABBV) stake by 5.8% in Q3 2026, selling an estimated $100K and leaving 6,300 shares worth $1.65M. The position accounts for 1.61% of the portfolio, ranked #18.

Parrish Capital first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.89M in Q4 2025. 2,051 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Parrish Capital held 6,300 shares of AbbVie worth $1.65M as of Q3 2026.
  • Parrish Capital sold 390 AbbVie shares in Q3 2026, an estimated $100K.
  • AbbVie made up 1.61% of Parrish Capital's portfolio in Q3 2026, its #18 holding.
  • Parrish Capital first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Parrish Capital's AbbVie position peaked at $1.89M in Q4 2025.
  • 2,051 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.